Cargando…
Bioorthogonal activation of prodrugs, for the potential treatment of breast cancer, using the Staudinger reaction
Selective prodrug activation at a tumor site is crucial to maximise the efficiency of chemotherapy approaches and minimise side effects due to off-site activation. In this paper, a new prodrug activation strategy is reported based on the bioorthogonal Staudinger reaction. The feasibility of this pro...
Autores principales: | Mitry, Madonna M. A., Boateng, Samuel Y., Greco, Francesca, Osborn, Helen M. I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429771/ https://www.ncbi.nlm.nih.gov/pubmed/37593579 http://dx.doi.org/10.1039/d3md00137g |
Ejemplares similares
-
Tetrazine-mediated bioorthogonal prodrug–prodrug activation
por: Neumann, Kevin, et al.
Publicado: (2018) -
Coordinating bioorthogonal reactions with two tumor-microenvironment-responsive nanovehicles for spatiotemporally controlled prodrug activation
por: Zuo, Liping, et al.
Publicado: (2020) -
Role of imine isomerization in the stereocontrol of the Staudinger reaction between ketenes and imines
por: Cossío, Fernando P., et al.
Publicado: (2021) -
Riboflavin as a bioorthogonal photocatalyst for the activation of a Pt(IV) prodrug
por: Alonso-de Castro, Silvia, et al.
Publicado: (2017) -
Bioorthogonal prodrug activation driven by a strain-promoted 1,3-dipolar cycloaddition
por: Matikonda, Siddharth S., et al.
Publicado: (2015)